Nov 15 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N
* Jannsen Inc says Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis
Nov 15 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N
* Jannsen Inc says Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis